Medically reviewed by Katlein Franca, MD Eczema is a chronic (long-lasting) skin condition that causes a dry, itchy rash. The ...

Atopic eczema is the most common form of the disease among New Zealanders. The skin condition causes dry, itchy, inflamed skin, affecting approximately one in three people at some point in their lives ...

A group of researchers have created four novel laboratory-developed tests that can distinguish between and subclassify atopic ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils Approval marks the first new treatment approach for ...

Many patients who achieved clear skin with tapinarof treatment maintained low disease activity after a treatment-free interval.

Airway inflammation plays a key role in allergic respiratory disease but is heterogeneous in nature. Most patients have type ...

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in MayInitial Results From First Two ...

PFIZER, a global biopharmaceutical company, today announced the availability of Cibinqo (abrocitinib) and Staquis (crisaborole) as new additions to the atopic dermatitis treatment spectrum in Malaysia ...

In this video, Robert Sidbury MD, MPH, division head of dermatology at Seattle Children’s Hospital and professor in the department of pediatrics at University of Washington School of Medicine, ...

Asthma and atopic dermatitis are chronic inflammatory diseases of the airways and the skin, respectively, which affect hundreds of millions of children and adults globally. Most patients with asthma ...

Autoimmune diseases occur when the immune system mistakenly attacks healthy cells. There are over 80 types, including Type 1 ...

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...